Objective: To evaluate the interaction between serum free insulin, insulin-like binding protein (IGFBP)-1 and leptin concentrations during puberty in insulin-dependent diabetes mellitus (IDDM). Design: Adolescent patients with IDDM (n ¼ 101; age .9 years, duration .2 years) from the Outpatient Clinic of the Department of Pediatrics at Oulu University Hospital, and non-diabetic controls, were recruited to the study. Free insulin, IGFBP-1, leptin and insulin antibody concentrations were measured from a fasting serum sample. Results: Free insulin concentrations were lower in the patients than in the controls (4:3^2:3 mU=l compared with 6:5^3:1 mU=l; P , 0:001), and there was an inverse correlation between free insulin and fasting blood glucose in the boys with diabetes (r ¼ 20:53; P , 0:001), whereas a positive correlation was observed between free insulin and leptin concentrations in the girls with diabetes (r ¼ 0:30; P ¼ 0:020). The IGFBP-1 concentrations were greater in the patients than in the controls (16:5^10:6 mg=l compared with 4:0^3:3; P , 0:001), and they correlated significantly with blood glucose (r ¼ 0:63; P , 0:001) and free insulin (r ¼ 20:35; P , 0:001). No significant difference was observed in the leptin concentrations between the patients and controls overall, despite greater total body fat in the girls with diabetes compared with the control girls. Conclusions: Adolescents with IDDM are characterised by morning hypoinsulinaemia and high circulating IGFBP-1 concentrations, which may contribute to insulin resistance and impaired metabolic control during puberty. The mechanism behind the increased total body fat in the postpubertal female patients remains to be determined.
Introduction
Metabolic control in adolescent patients with insulindependent diabetes mellitus (IDDM) is influenced by deteriorating peripheral insulin sensitivity (1, 2) as a result of hormonal changes during puberty and relative hypoinsulinism in the hepatic portal circulation, whereas in healthy adolescents the increased insulin resistance is compensated by increased insulin secretion (3) . The circulating concentrations of insulinlike growth factor binding protein (IGFBP)-1 decrease with advancing puberty in healthy adolescents, reflecting the physiological increase in biologically active insulin in the portal circulation (4), whereas adolescent patients with IDDM and with non-optimal glucose control have high serum IGFBP-1 concentrations concurrently with low free insulin concentrations, especially in the morning (5) .
In addition to these changes induced by hypoinsulinism in IDDM, increasing proportions of body fat during puberty in girls with diabetes may affect the efficiency of biologically active insulin by inducing peripheral insulin resistance. Body fat and leptin concentrations increase during puberty in girls, whereas in boys the leptin concentrations decrease or remain stable in relation to fat-free mass (6 -9) .
The majority of patients with insulin-treated diabetes still develop insulin antibodies in response to exogenous insulin, in spite of the extensive use of human insulin (10) . As a consequence, the remaining free insulin represents the biologically active hormone in patients with insulin antibodies.
The present study focused on the interactions between serum free insulin, IGFBP-1, and leptin during puberty in adolescents with IDDM.
Oulu, Finland, consented to take part in the study. The chronological age of the patients ranged from 9 to 18 years, and the duration of diabetes was more than 2 years. All the patients with IDDM who were younger than 15 years of age attended this outpatient clinic until the age of 16 -18 years. One patient was excluded because of Down's syndrome and hypothyroidism. One hundred healthy age-and sex-matched control individuals were recruited from nearby schools. All the patients were receiving intensified insulin treatment, with three to four subcutaneous insulin injections per day. The characteristics of the patients and controls are shown in Table 1 , and the study population has been described in detail previously (11) . All the patients and controls and the parents of each gave an informed consent to the study, which was approved by the Ethics Committee of the Medical Faculty, University of Oulu, Oulu, and was carried out according to the provisions of the Declaration of Helsinki.
Study design
The Tanner pubertal stages were assessed by one of the investigators (PHR) during the initial clinical examination, by breast staging in the girls and genital staging in the boys (12) . A testicular length . 20 mm, or a volume of the larger testicle . 2.0 ml [assessed as 0.52 £ length (cm) £ width squared (cm)] (13) was regarded as indicating the start of pubertal development in the boys. Height (cm) was measured using a Harpenden stadiometer, and the mean of three separate, consecutive measurements was taken as the actual height. Weight (kg) was measured on a digital weight scale with a precision of 0.1 kg. Relative height for age (SDS) and relative weight for height (%) were assessed from the Finnish growth charts (14) .
The biceps, triceps and subscapular skin folds were assessed on the right side as described earlier (15) , as the mean of three consecutive measurements performed with a Harpenden skinfold calliper. Body density was estimated with regression equations based on the triceps and subscapular skin folds (16) , and the total body fat (%) was calculated according to Keys & Brožek (17) .
Laboratory methods
A blood sample was obtained from the antecubital vein between 0700 and 0800 h after the individual had undergone an overnight fast, before the morning insulin injection and breakfast. The serum was stored at 2 20 8C until required for analysis. The fasting blood glucose concentration (mmol/l) was measured with a bedside glucometer.
Serum free insulin concentrations Serum free insulin concentrations (mU/l) were quantified with an enzymelinked immunosorbent assay (DAKO Diagnostics Ltd, Ely, Cambridgeshire, UK) after pretreatment of the sample with polyethylene glycol to precipitate insulin -insulin antibody complexes. The sensitivity of the assay was 0.5 mU/l and the intra-and interassay coefficients of variation (CV) were less than 7.5% and 9.3% respectively. One girl with IDDM who exhibited a very 
Statistical analysis
The results are expressed as means^S.D. or range. Variables with skewed distribution were log-transformed, the differences between two means were evaluated with the unpaired Student's t-test, and the 95% confidence interval (CI) for the difference between two means was determined. The leptin concentrations were adjusted for total body fat before the patients and controls were compared within various pubertal stages. Linear trends in variables in relation to pubertal maturation were assessed with one-way analysis of variance (ANOVA). Linear regression analysis was used for assessing correlations and to determine independent associations between variables. The statistical analyses were performed with SPSS 10.0 (SPSS Inc., Chicago, IL, USA).
Results

Free insulin
The serum free insulin concentrations were significantly lower in the patients than in the controls (4:7^2:3 mU=l compared with 6:5^3:1 mU=l; 95% CI 2 1.8 to 2 1.3), and this was true for both the boys (3:9^2:2 mU=l compared with 6:3^3:0 mU=l; 95% CI 2 2.1 to 2 1.2) and the girls (4:6^2:3 mU=l compared with 6:7^3:2 mU=l; 95% CI 2 1.8 to 2 1.2; P , 0:001 for all). The free insulin concentrations were significantly lower in the patients than in the controls both before and after puberty (Fig. 1) . 
IGFBP-1
Serum IGFBP-1 concentrations were significantly greater in the patients than in the controls (16:5^10:6 mg=l compared with 4:0^3:3 mg=l; 95% CI 3.6 to 5.6; P , 0:001) and the concentrations were greater in the patients at each pubertal stage except at Tanner stage II in the girls (Fig. 2) , whereas no significant difference in the IGFBP-1 concentrations was observed between girls and boys with diabetes ðP ¼ 0:07Þ. The IGFBP-1 concentrations decreased with pubertal maturation in the controls (F ¼ 63:1; P , 0:001; one-way ANOVA), whereas they remained high in the patients with IDDM (F ¼ 3:9; P ¼ 0:051).
Leptin
Leptin concentrations were greater in the girls than in the boys, both among the patients (14:5^6:0 mg=l compared with 7:0^4:3 mg=l; 95% CI 1.8 to 2.8; P , 0:001) and among the controls (12:8^5:7 mg=l compared with 6:3^5:3 mg=l; 95% CI 1.9 to 3.1; P , 0:001), whereas they did not differ significantly between the patients and controls overall ðP ¼ 0:08Þ. The leptin concentrations within the pubertal stages are shown in Fig. 3 . Serum leptin concentrations increased with pubertal maturation in the girls with diabetes (F ¼ 19:1; P , 0:001) and in the non-diabetic girls (F ¼ 17:2; P , 0:001), whereas they decreased in the boys with diabetes (F ¼ 23:3; P , 0:001) and in the control boys (F ¼ 18:0; P , 0:001; one-way ANOVA). By the end of puberty, total body fat was significantly greater in the girls with diabetes than in the control girls (Table 2 ).
Insulin antibodies
The median concentration of insulin antibodies was 96 RU in the boys (mean 187 RU; range 1.0 -1031 RU) and 108 RU in the girls (mean 200 RU; range 1.0-1941 RU). Twelve boys (26%) and 13 girls (25%) had a high insulin antibody concentrations (. 200 RU) and the proportion of those with high concentrations of insulin antibodies was comparable among the prepubertal (27%), pubertal (24%) and postpubertal (26%) patients. The patients with high insulin antibody concentrations did not differ from those with insulin antibodies , 200 RU with respect to serum free insulin concentration, age, diabetes duration, long-term HbA 1c , age at disease presentation, or fasting blood glucose concentration.
Correlations
Free insulin concentrations correlated significantly with the daily insulin dose in the girls (r ¼ 0:42; P ¼ 0:002), but not in the boys (r ¼ 2 0.006, P ¼ 0:97), whereas they were inversely related to fasting blood glucose in the boys with diabetes (r ¼ 20:53; P , 0:001) and positively related to HbA 1c (r ¼ 0:37; P ¼ 0:005) and leptin concentrations (r ¼ 0:30; P ¼ 0:020) in the girls with diabetes. IGFBP-1 concentrations correlated significantly with blood glucose (r ¼ 0:63; P , 0:001) and free insulin (r ¼ 20:35; P , 0:001) in the entire group of patients. They correlated with leptin concentrations in the control girls (r ¼ 20:65; P , 0:001), but no significant correlation was observed in the girls or in the boys with diabetes or in the control boys. 
Discussion
High fasting IGFBP-1 concentrations were demonstrated in young patients with IDDM at each pubertal stage, whereas peripheral insulin concentrations were lower than in healthy adolescents, the lowest concentrations being observed in prepubertal and postpubertal patients.
IGFBP-1 concentrations decrease in healthy adolescents as puberty advances, reflecting increasing insulin concentrations (21) , whereas patients with IDDM have high hepatic IGFBP-1 production induced by portal hypoinsulinaemia. As in healthy individuals, in patients with IDDM the circulating IGFBP-1 concentrations have a diurnal variation, with maximum values during the night and morning, and the highest concentrations seen in the presence of low insulin concentrations (22) . As the fasting serum IGFBP-1 concentrations correlate well with 24-h mean values in adults with and without IDDM (22) , it might be assumed that high IGFBP-1 concentrations in the present study reflected the concentrations during the previous night and early morning. High IGFBP-1 and low free insulin concentrations have been observed during puberty in diabetes, in spite of therapeutic administration of insulin (23) ; this, together with the observations of high IGFBP-1 in association with the dawn phenomenon in adolescent patients (24) , is consistent with the present observations. Serum free insulin was related to the daily insulin dose in girls with diabetes, but not in boys with diabetes. This, together with the inverse association of free insulin with fasting blood glucose in the present study, might support the assumption of an insufficient subcutaneous insulin supply in the adolescent boys with diabetes. In healthy pubertal adolescents, insulin resistance is restricted to the peripheral tissues, and he physiological insulin supply in the portal blood is sufficient to prevent hepatic glucose overproduction (3), whereas the obvious lack of insulin in adolescent patients leads to redundant hepatic glucose production and thereby to increased peripheral insulin resistance.
Serum leptin concentrations increased in the girls and decreased in the boys, along with pubertal maturation and in parallel with the changes observed in total body fat. This finding is in agreement with those of a previous follow-up study (9) and with some cross-sectional surveys (6, 7, 25, 26) involving young patients with IDDM and healthy adolescents. However, total circulating leptin concentrations were lower in the present patients than in the healthy adolescents, in contrast to some previous reports (6, 9) . In spite of a significantly increased proportion of body fat by the end of puberty, the girls with IDDM in the present study had serum leptin concentrations similar to those seen in the non-diabetic girls. This suggests that factors other than hyperleptinaemia are responsible for the accumulation of fat tissue in young females with IDDM. Although it has been speculated that repetitive hyperinsulinaemia developing in association with repeated insulin injections may stimulate the synthesis of leptin (6) , no change in leptin concentrations was observed in a hyperinsulinaemic clamp study of adult men with IDDM (27) . The decrease in leptin concentrations with advancing puberty in the present male participants may be explained by a reduction in total fat, or an increase in fat-free mass (9) , changes in androgen secretion, or low circulating concentrations of free insulin. The present observations show that adolescents with IDDM do not experience the physiological decrease in circulating IGFBP-1 concentrations during puberty that are seen in healthy adolescents. Early morning hypoinsulinaemia is related to high IGFBP-1 concentrations, and presumably the relatively low leptin concentrations also reflect low insulin supply in the patients. The increased IGFBP-1 concentrations may reduce the local effects of IGF-I (28), and because IGF-I plays an important part in the feedback regulation of growth hormone, a reduced IGF-I effect might lead to increased secretion of growth hormone in pubertal individuals with IDDM (29) . Sustained secretion of growth hormone has been implicated in the development of insulin resistance and poor metabolic control in adolescents with IDDM. Suppression of the IGFBP-1 concentrations would require adequate insulin concentrations in the portal circulation, which can not easily be achieved with the present modes of insulin replacement therapy.
